These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 6062673)
41. Etrafon: a three year study. Cook RW Pa Med; 1967 Feb; 70(1):63-5. PubMed ID: 5341525 [No Abstract] [Full Text] [Related]
42. The pharmacological treatment of delusional depression. Spiker DG; Weiss JC; Dealy RS; Griffin SJ; Hanin I; Neil JF; Perel JM; Rossi AJ; Soloff PH Am J Psychiatry; 1985 Apr; 142(4):430-6. PubMed ID: 3883815 [TBL] [Abstract][Full Text] [Related]
43. [Use in general and psychosomatic medicine of 2 associations with mixed, anti-depressive and tranquilizing action (amitriptyline + perphenazine)]. Ropert R Therapeutique; 1970 May; 46(5):527-30. PubMed ID: 5430225 [No Abstract] [Full Text] [Related]
44. [Double blind comparative study of Trilifan and Mutanxion in the treatment of functional digestive disorders]. Truchot R Therapeutique; 1971 Mar; 47(3):261-3. PubMed ID: 4934009 [No Abstract] [Full Text] [Related]
45. [Further observations on the effects of the treatment with amitriptyline and perphenazine in essential headache]. Pisani RA; Lazzari R; Franzese A; Arzilli A Clin Ter; 1987 Sep; 122(5):345-50. PubMed ID: 2972451 [No Abstract] [Full Text] [Related]
46. Doxepin versus amitriptyline in depression: a sequential double-blind study. Grof P; Saxena B; Cantor R; Daigle L; Hetherington D; Haines T Curr Ther Res Clin Exp; 1974 May; 16(5):470-6. PubMed ID: 4209062 [No Abstract] [Full Text] [Related]
47. [Therapeutic trial of Mutanxion and Mutaspline in psychiatry]. Mouren P; Giudicelli S; Scarrone JJ; D'omezon G Mars Med; 1971; 108(3):243-5. PubMed ID: 5576123 [No Abstract] [Full Text] [Related]
48. Treating anxiety and depression in the elderly. A double blind crossover evaluation of two widely used tranquilizers. Beber CR J Fla Med Assoc; 1971 Mar; 58(3):35-8. PubMed ID: 4925593 [No Abstract] [Full Text] [Related]
49. A comparison of two drug treatments in depressive illness. Browne MW Br J Psychiatry; 1969 Jun; 115(523):693-6. PubMed ID: 4896804 [No Abstract] [Full Text] [Related]
50. [Comparative evaluation of nortriptyline, amitriptyline and of a placebo in the treatment of anxiety and depressive disorders]. Taverna P; Ferrari G Minerva Med; 1969 Jun; 60(49):2417-31. PubMed ID: 5802654 [No Abstract] [Full Text] [Related]
51. Psychogenic headaches with mixed anxiety and depression. Diamond S IMJ Ill Med J; 1975 Mar; 147(3):268-9. PubMed ID: 236227 [No Abstract] [Full Text] [Related]
52. Severe emotional disturbance associated with physical illness. I. Double-blind study. Coleman J Psychosomatics; 1969; 10(3):32-5. PubMed ID: 4898444 [No Abstract] [Full Text] [Related]
55. A comparison of doxepin with diazepam and amitriptyline in general practice. Jones BL; Eastgate NO; Downey PG; Davies LJ N Z Med J; 1972 Sep; 76(484):174-9. PubMed ID: 4508743 [No Abstract] [Full Text] [Related]
56. Amitriptyline and amitriptyline-with-perphenazine in depression--a retrospective study. Chacón C; Downham ET Br J Psychiatry; 1967 Feb; 113(495):201-7. PubMed ID: 6032480 [No Abstract] [Full Text] [Related]
57. The treatment of anxiety and depression in the allergic patient. Sanger MD Ann Allergy; 1969 Oct; 27(10):506-10. PubMed ID: 4918116 [No Abstract] [Full Text] [Related]
58. Clinical evaluation of doxepin in anxious depressed outpatients. Goldstein BJ; Pinosky DG Curr Ther Res Clin Exp; 1969 Apr; 11(4):169-77. PubMed ID: 4976335 [No Abstract] [Full Text] [Related]
59. Amitriptyline and perphenazine in depressive illness. A controlled trial. Haider I Br J Psychiatry; 1967 Feb; 113(495):195-9. PubMed ID: 5340301 [No Abstract] [Full Text] [Related]